Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience.
Fiche publication
Date publication
mai 2022
Journal
Respiratory medicine and research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr OLLAND Anne
Tous les auteurs :
Leroux J, Hirschi S, Essaydi A, Bohbot A, Degot T, Schuller A, Olland A, Kessler R, Renaud-Picard B
Lien Pubmed
Résumé
Bronchiolitis obliterans syndrome (BOS) is the main limitation to long-term survival following lung transplantation. Several studies generated promising results regarding the efficacy of extracorporeal photopheresis (ECP) in BOS management. We aimed to compare FEV1 evolution in ECP-treated versus non-ECP treated patients among BOS recipients.
Mots clés
Bronchiolitis obliterans syndrome, Extracorporeal photopheresis, Lung transplantation
Référence
Respir Med Res. 2022 05;81:100913